Literature DB >> 31875912

Ovarian Androgens Maintain High GnRH Neuron Firing Rate in Adult Prenatally-Androgenized Female Mice.

Eden A Dulka1, Laura L Burger1, Suzanne M Moenter1,2,3.   

Abstract

Changes in gonadotropin-releasing hormone (GnRH) release frequency from the brain help drive reproductive cycles. In polycystic ovary syndrome (PCOS), persistent high GnRH/luteinizing hormone (LH) frequency disrupts cycles and exacerbates hyperandrogenemia. Adult prenatally-androgenized (PNA) mice exhibit increased GnRH neuron firing rate, elevated ovarian androgens, and disrupted cycles, but before puberty, GnRH neuron activity is reduced in PNA mice compared with controls. We hypothesized that ovarian feedback mediates the age-dependent change in GnRH neuron firing rate in PNA vs control mice. Extracellular recordings of green fluorescent protein (GFP)-identified GnRH neurons were made 5 to 7 days after sham-surgery, ovariectomy (OVX), or, in adults, after OVX plus replacement of sub-male androgen levels with dihydrotestosterone implants (OVX + DHT). In 3-week-old mice, OVX did not affect GnRH neuron firing rate in either group. In adult controls, OVX increased GnRH neuron firing rate, which was further enhanced by DHT. In adult PNA mice, however, OVX decreased GnRH neuron firing rate, and DHT restored firing rate to sham-operated levels. In contrast to the differential effects of ovarian feedback on GnRH neuron firing rate, serum LH increased after OVX in both control and PNA mice and was not altered by DHT. Pituitary gene expression largely reflected changes expected with OVX, although in PNA but not control mice, DHT treatment increased Lhb expression. These results suggest prenatal androgen exposure programs marked changes in GnRH neuron regulation by homeostatic steroid feedback. PNA lowers GnRH neuron activity in low-steroid states (before puberty, OVX), and renders activity in adulthood dependent upon ongoing exposure to elevated ovarian androgens. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  androgen; neuroendocrine; polycystic ovary syndrome; puberty

Mesh:

Substances:

Year:  2020        PMID: 31875912      PMCID: PMC7397485          DOI: 10.1210/endocr/bqz038

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  81 in total

Review 1.  Androgen excess is the key element in polycystic ovary syndrome.

Authors:  Ricardo Azziz
Journal:  Fertil Steril       Date:  2003-08       Impact factor: 7.329

2.  Development of gonadotropin-releasing hormone secretion and pituitary response.

Authors:  Katarzyna M Glanowska; Laura L Burger; Suzanne M Moenter
Journal:  J Neurosci       Date:  2014-11-05       Impact factor: 6.167

3.  Long-Term Recordings of Arcuate Nucleus Kisspeptin Neurons Reveal Patterned Activity That Is Modulated by Gonadal Steroids in Male Mice.

Authors:  Charlotte Vanacker; Manuel Ricu Moya; R Anthony DeFazio; Michael L Johnson; Suzanne M Moenter
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

4.  Effect of steroid milieu on gonadotropin-releasing hormone-1 neuron firing pattern and luteinizing hormone levels in male mice.

Authors:  Justyna Pielecka; Suzanne M Moenter
Journal:  Biol Reprod       Date:  2006-02-01       Impact factor: 4.285

5.  Prenatal androgen exposure programs metabolic dysfunction in female mice.

Authors:  Alison V Roland; Craig S Nunemaker; Susanna R Keller; Suzanne M Moenter
Journal:  J Endocrinol       Date:  2010-08-16       Impact factor: 4.286

Review 6.  Hypothalamic dysfunction.

Authors:  J C Marshall; C A Eagleson; C R McCartney
Journal:  Mol Cell Endocrinol       Date:  2001-10-25       Impact factor: 4.102

7.  Both Estrogen and Androgen Modify the Response to Activation of Neurokinin-3 and κ-Opioid Receptors in Arcuate Kisspeptin Neurons From Male Mice.

Authors:  Kristen A Ruka; Laura L Burger; Suzanne M Moenter
Journal:  Endocrinology       Date:  2015-11-12       Impact factor: 4.736

8.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

Authors:  Wendy A March; Vivienne M Moore; Kristyn J Willson; David I W Phillips; Robert J Norman; Michael J Davies
Journal:  Hum Reprod       Date:  2009-11-12       Impact factor: 6.918

9.  Phasic firing enhances vasopressin release from the rat neurohypophysis.

Authors:  A Dutton; R E Dyball
Journal:  J Physiol       Date:  1979-05       Impact factor: 5.182

Review 10.  How to Contribute to the Progress of Neuroendocrinology: Discovery of GnIH and Progress of GnIH Research.

Authors:  Kazuyoshi Tsutsui; Takayoshi Ubuka
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-12       Impact factor: 5.555

View more
  5 in total

Review 1.  The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome.

Authors:  Christopher R McCartney; Rebecca E Campbell; John C Marshall; Suzanne M Moenter
Journal:  J Neuroendocrinol       Date:  2022-01-26       Impact factor: 3.870

Review 2.  Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms.

Authors:  Alexander O Shpakov
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-08

3.  Prenatal androgen treatment impairs the suprachiasmatic nucleus arginine-vasopressin to kisspeptin neuron circuit in female mice.

Authors:  Bradley B Jamieson; Aleisha M Moore; Dayanara B Lohr; Simone X Thomas; Lique M Coolen; Michael N Lehman; Rebecca E Campbell; Richard Piet
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

4.  Abnormal GnRH Pulsatility in Polycystic Ovary Syndrome: Recent Insights.

Authors:  Christopher R McCartney; Rebecca E Campbell
Journal:  Curr Opin Endocr Metab Res       Date:  2020-04-23

5.  Chemogenetic Suppression of GnRH Neurons during Pubertal Development Can Alter Adult GnRH Neuron Firing Rate and Reproductive Parameters in Female Mice.

Authors:  Eden A Dulka; R Anthony DeFazio; Suzanne M Moenter
Journal:  eNeuro       Date:  2020-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.